Fig. 3From: Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from bloodcfDNA quantity after cfDNA isolation. Average total amount of isolated cfDNA (ng) for all cfDNA isolation kits for the different amounts of spiked-in fragmented RKO DNA to the normal plasma pool, determined by fluorometric quantificationBack to article page